{"id":"https://openalex.org/W4324136754","doi":"https://doi.org/10.1200/jco.2023.41.6_suppl.556","title":"Systematic literature review and testing of HER2 status in urothelial carcinoma (UC).","display_name":"Systematic literature review and testing of HER2 status in urothelial carcinoma (UC).","publication_year":2023,"publication_date":"2023-02-20","ids":{"openalex":"https://openalex.org/W4324136754","doi":"https://doi.org/10.1200/jco.2023.41.6_suppl.556"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.6_suppl.556","doi":"https://doi.org/10.1200/jco.2023.41.6_suppl.556","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.6_suppl.556","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031234862","display_name":"Vadim S. Koshkin","orcid":"https://orcid.org/0000-0003-2277-8668","observed_orcids":["https://orcid.org/0000-0003-2277-8668"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vadim S Koshkin","raw_affiliation_strings":["University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002979775","display_name":"Christine Boyiddle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Boyiddle","raw_affiliation_strings":["Seagen Inc., Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seagen Inc., Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050118261","display_name":"Naomi R. M. Schwartz","orcid":"https://orcid.org/0000-0003-0656-7801","observed_orcids":["https://orcid.org/0000-0003-0656-7801"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naomi Schwartz","raw_affiliation_strings":["Seagen Inc., Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seagen Inc., Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009648434","display_name":"Judy Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judy Yu","raw_affiliation_strings":["Seagen Inc., Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seagen Inc., Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011227173","display_name":"Kristina S. Yu","orcid":"https://orcid.org/0000-0002-8057-9897","observed_orcids":["https://orcid.org/0000-0002-8057-9897"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristina S. Yu","raw_affiliation_strings":["Seagen Inc., Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seagen Inc., Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109645345","display_name":"Ashley Kang","orcid":"https://orcid.org/0009-0009-3670-8434","observed_orcids":["https://orcid.org/0009-0009-3670-8434"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashley Kang","raw_affiliation_strings":["Curta Inc., Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curta Inc., Seattle, WA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109959200","display_name":"Lisa M. Bloudek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Bloudek","raw_affiliation_strings":["Curta Inc., Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curta Inc., Seattle, WA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111060234","display_name":"Qijun Fang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qijun Fang","raw_affiliation_strings":["Roche Diagnostic Solutions, Tucson, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Diagnostic Solutions, Tucson, AZ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089542534","display_name":"Johanna M. Schafer","orcid":"https://orcid.org/0000-0001-7834-5621","observed_orcids":["https://orcid.org/0000-0001-7834-5621"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johanna M. Schafer","raw_affiliation_strings":["Roche, Oro Valley, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Oro Valley, AZ","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103147452","display_name":"Amanda F. Baker","orcid":"https://orcid.org/0000-0002-0670-5381","observed_orcids":["https://orcid.org/0000-0002-0670-5381"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda F. Baker","raw_affiliation_strings":["Ventana - Roche, Oro Valley, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ventana - Roche, Oro Valley, AZ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029520101","display_name":"Farzaneh H. Sayedian","orcid":"https://orcid.org/0000-0002-6336-1319","observed_orcids":["https://orcid.org/0000-0002-6336-1319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farzaneh H. Sayedian","raw_affiliation_strings":["Roche Tissue Diagnostics, Tucson, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Tissue Diagnostics, Tucson, AZ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091485339","display_name":"Emilie Scherrer","orcid":"https://orcid.org/0000-0003-3184-3724","observed_orcids":["https://orcid.org/0000-0003-3184-3724"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emilie Scherrer","raw_affiliation_strings":["Seagen Inc., Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seagen Inc., Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4875,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.42914172,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"41","issue":"6_suppl","first_page":"556","last_page":"556"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.6762999892234802,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.6762999892234802,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.2946999967098236,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.011500000022351742,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-status","display_name":"HER2 status","score":0.8230000138282776},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/her2-amplification","display_name":"HER2 amplification","score":0.8809999823570251},{"id":"https://openalex.org/keywords/her2-expression","display_name":"HER2 expression","score":0.7300000190734863},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.8659999966621399},{"id":"https://openalex.org/keywords/in-situ-hybridization","display_name":"in situ hybridization","score":0.9850000143051147},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/her2-low","display_name":"HER2-low","score":0.38499999046325684},{"id":"https://openalex.org/keywords/her2-negative","display_name":"HER2-negative","score":0.6029999852180481},{"id":"https://openalex.org/keywords/her2-positive","display_name":"HER2-positive","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.8271376490592957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7176814675331116},{"id":"https://openalex.org/C2776643354","wikidata":"https://www.wikidata.org/wiki/Q5113886","display_name":"Chromogenic in situ hybridization","level":5,"score":0.7029933929443359},{"id":"https://openalex.org/C7602840","wikidata":"https://www.wikidata.org/wiki/Q746284","display_name":"Gene duplication","level":3,"score":0.5585466027259827},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.5331921577453613},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4696114659309387},{"id":"https://openalex.org/C167752854","wikidata":"https://www.wikidata.org/wiki/Q220677","display_name":"Chromosome 17 (human)","level":4,"score":0.45484858751296997},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.45347148180007935},{"id":"https://openalex.org/C2781294515","wikidata":"https://www.wikidata.org/wiki/Q2733470","display_name":"Stain","level":3,"score":0.4513222575187683},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4276425242424011},{"id":"https://openalex.org/C81439078","wikidata":"https://www.wikidata.org/wiki/Q2304142","display_name":"In situ hybridization","level":4,"score":0.427223801612854},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.41856878995895386},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4169619381427765},{"id":"https://openalex.org/C74864618","wikidata":"https://www.wikidata.org/wiki/Q2332446","display_name":"Staining","level":2,"score":0.33517083525657654},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3272148668766022},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.317011296749115},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2923768162727356},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.2703729569911957},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.23518040776252747},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1697629690170288},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07789289951324463},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.6_suppl.556","doi":"https://doi.org/10.1200/jco.2023.41.6_suppl.556","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.6_suppl.556","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4306973340","https://openalex.org/W4409487606","https://openalex.org/W1517905849","https://openalex.org/W2602107411","https://openalex.org/W2005263957","https://openalex.org/W2034838154","https://openalex.org/W4322722625","https://openalex.org/W4281624679","https://openalex.org/W4220869628","https://openalex.org/W4213275188"],"abstract_inverted_index":{"556":[0],"Background:":[1],"Recent":[2],"clinical":[3],"trials":[4],"suggest":[5,409],"an":[6,75,230],"emerging":[7],"role":[8,413],"for":[9,39,178,194,234,253,289,373,404,414,417],"HER2-targeted":[10,415],"therapy":[11,416],"in":[12,30,42,68,81,94,341,365],"locally":[13],"advanced":[14],"and":[15,24,51,70,90,105,193,211,271,327,375,395],"metastatic":[16],"UC":[17,82,172,310,354,389],"(LA/mUC).":[18],"The":[19,100,336,357],"prevalence":[20],"of":[21,47,59,65,74,78,111,170,269,294,362,370,388],"HER2":[22,40,66,79,84,113,135,179,195,201,223,237,259,290,337,363,377,396],"expression":[23,41,86,181],"gene":[25,91,136,196,238,338],"amplification":[26,92,137,197,239],"(encoded":[27],"by":[28,87,93,175,242],"ERBB2)":[29],"LA/mUC":[31,43,69,112],"has":[32],"not":[33,45,53],"been":[34],"well":[35],"defined,":[36],"as":[37,128,142,146,152],"testing":[38],"is":[44,52],"part":[46],"current":[48],"routine":[49],"practice":[50],"standardized.":[54],"We":[55,119],"report":[56],"(1)":[57,99,248],"findings":[58],"a":[60,219,243,368,410],"systematic":[61],"literature":[62],"review":[63],"(SLR)":[64],"status":[67,80,114,364,397],"(2)":[71,163,307],"preliminary":[72],"results":[73],"ongoing":[76],"evaluation":[77],"assaying":[83],"protein":[85,180],"immunohistochemistry":[88],"(IHC)":[89],"situ":[95],"hybridization":[96],"(ISH).":[97],"Methods:":[98],"SLR":[101,358],"used":[102,120],"databases":[103],"PubMed":[104],"EMBASE":[106],"to":[107,159,285,299],"identify":[108],"English-language":[109],"studies":[110,257,279],"published":[115],"Jan2000":[116],"\u2013":[117],"Oct2021.":[118],"the":[121,183,199,254,277,292],"following":[122],"definitions:":[123],"HER2-positive":[124],"(HER2+)":[125],"was":[126,140,150,226,240,339,399],"defined":[127,141,151,241],"IHC":[129,132,143,147,153,191,224],"3+,":[130],"or":[131,145,351,393],"2+":[133],"with":[134,265,401,406],"(Amp+).":[138],"HER2-low":[139,322],"2+/Amp\u2013,":[144],"1+.":[148],"HER2-zero":[149,330],"0.":[154],"Weighted":[155],"averages":[156],"were":[157,173,274,314,321,329,391],"calculated":[158],"estimate":[160],"population":[161],"prevalence.":[162],"Commercially":[164],"sourced,":[165],"formalin-fixed":[166],"paraffin-embedded":[167],"surgical":[168],"resections":[169],"primary":[171],"evaluated":[174],"trained":[176],"readers":[177],"using":[182,198,218,383],"VENTANA":[184,200],"HER2/neu":[185],"(4B5)":[186],"Rabbit":[187],"Monoclonal":[188],"Primary":[189],"Antibody":[190],"assay":[192],"Dual":[202],"ISH":[203],"DNA":[204],"Probe":[205],"Cocktail":[206],"that":[207,402],"detects":[208],"both":[209],"ERBB2":[210],"its":[212],"residing":[213],"chromosome,":[214],"chromosome":[215],"17":[216],"(Chr17),":[217],"two-color":[220],"chromogenic":[221],"stain.":[222],"staining":[225],"scored":[227],"based":[228],"on":[229],"established":[231],"scoring":[232,272],"algorithm":[233],"gastric":[235],"cancer.":[236],"HER2/Chr17":[244],"ratio":[245],"\u22652.0.":[246],"Results:":[247],"Of":[249,308],"744":[250],"records":[251],"screened":[252],"SLR,":[255],"45":[256],"reported":[258,403],"status,":[260,291],"including":[261],"10,602":[262],"patients":[263],"(pts)":[264],"LA/mUC.":[266,407],"A":[267],"variety":[268],"assays":[270],"guidelines":[273],"used.":[275],"In":[276,379],"4":[278],"(862":[280],"pts)":[281],"reporting":[282],"data":[283],"applicable":[284],"our":[286,380],"predefined":[287],"criteria":[288],"percentage":[293],"HER2+":[295,315,392],"ranged":[296],"from":[297],"6.7%":[298],"37.5%":[300],"(weighted":[301],"average,":[302],"13.1%;":[303],"95%":[304,317,324,332],"CI,":[305,318,325],"7.3%\u201318.8%).":[306],"252":[309],"samples":[311,390],"evaluated,":[312],"38":[313],"(15.1%;":[316],"11.2%\u201320.0%),":[319],"74":[320],"(29.4%;":[323],"24.1%\u201335.3%),":[326],"140":[328],"(55.5%;":[331],"CI:":[333],"49.4%\u201361.6%;":[334],"Table).":[335],"amplified":[340],"31":[342],"(12.3%),":[343],"among":[344],"them":[345],"24":[346],"(77.4%)":[347],"at":[348],"stage":[349],"III":[350],"IV":[352],"muscle-invasive":[353],"(MIUC).":[355],"Conclusions:":[356],"revealed":[359],"wide":[360],"variability":[361],"LA/mUC,":[366],"highlighting":[367],"lack":[369],"standardized":[371,384],"methods":[372],"assessing":[374],"defining":[376],"status.":[378],"large":[381],"study":[382],"laboratory":[385],"methods,":[386],"44%":[387],"HER2-low,":[394],"distribution":[398],"consistent":[400],"pts":[405],"Results":[408],"potentially":[411],"important":[412],"UC.":[418],"[Table:":[419],"see":[420],"text]":[421]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-03-15T00:00:00"}